Sign in

dfcicancerbio.bsky.social

@dfcicancerbio.bsky.social
48 followers 14 following 1 posts
PostsRepliesMedia
Reposted by @dfcicancerbio.bsky.social
Dana-Farber Cancer Institute @danafarber.bsky.social · 11/07/2025
A new study led by Dipanjan Chowdhury, PhD, co-director of our Center for BRCA and Related Genes, uncovers why some cancers resist PARP inhibitors. The findings could help guide more personalized treatment strategies. Learn more about the study: bit.ly/4ko5CAq
bit.ly
Double Negative in Cells Could Undermine PARP Inhibitors
Published: June 10, 2025Updated: June 11, 2025Written by: Beth DoughertyThere are two ways to fix things: the quick way and the careful one. In cancer, cells with BRCA1 mutations tend to choose the quick fix, leaving them vulnerable to medicines like PARP inhibitors.   PARP inhibitors cause DNA to break. When broken strands and sketchy repairs ... Read more
021
Reposted by @dfcicancerbio.bsky.social
Milka Kostic @milkakostic.bsky.social · 30/06/2025
We are looking to hire an Assistant/Associate Professor interested in creating an innovative (and exciting) program of research in chemical biology, medicinal chemistry, ML/AI, drug discovery - all in the context of cancer biology! careers.dana-farber.org/job/11813/as...
careers.dana-farber.org
Faculty/Health Educator Job: Assistant/Associate Professor, Chemical Biology at Dana-Farber Cancer Institute in 450 Brookline Ave, Boston, MA
Assistant/Associate Professor, Chemical Biology job
01211
Reposted by @dfcicancerbio.bsky.social
Klingenstein Philanthropies @klingensteinorg.bsky.social · 01/07/2025
Congratulations Xin Gu, Ph.D., recipient of a Klingenstein Fellowship Award in Neuroscience for the project, "Elucidating the Role of the Midnolin-Proteasome Pathway in the Central Nervous System." @xingulab.bsky.social xingulab.dana-farber.org
142
Reposted by @dfcicancerbio.bsky.social
Dana-Farber News @danafarbernews.bsky.social · 07/07/2025
New research in @pnas.org led by @danafarber.bsky.social’s Yubao Wang, PhD, in the lab of Tom Roberts, PhD, explored an engineered, degradable form of a small viral protein and made new insights into a key cell growth pathway often hijacked by cancer cells. Read more: bit.ly/4ezpMpE
021
Reposted by @dfcicancerbio.bsky.social
Dana-Farber Cancer Institute @danafarber.bsky.social · 08/07/2025
In collaboration with Beth Israel Deaconess Medical Center, our new dedicated cancer hospital, projected to open in 2031, will strengthen Boston’s position as a global leader in oncology — and expand access to the most advanced care for patients across the region. bit.ly/402eQej
bit.ly
Following State and City Approvals, New Cancer Hospital and Clinical Collaboration Enters Next Phase | Dana-Farber Cancer Institute
With the recent completion of a multi-agency, state and city regulatory process, the clinical collaboration among Dana-Farber Cancer Institute (Dana-Farber), Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical Faculty Physicians at BIDMC (HMFP) is moving forward. The collaboration will support a new Dana-Farber cancer hospital, and the joint clinical teams are developing comprehensive plans to transform cancer care around the world and push the boundaries of research and innovation.
043
Reposted by @dfcicancerbio.bsky.social
Boston Protein Design and Modeling Club @bpdmc.org · 09/07/2025
quick reminder to join us tonight at @harvardmed.bsky.social for a great talk by Colby Ford @colby.tuple.xyz
023
Reposted by @dfcicancerbio.bsky.social
Xin Gu Lab at DFCI/HMS @xingulab.bsky.social · 17/06/2025
So happy and proud to see our story online!! Thank you, the midnolin team!
295
dfcicancerbio.bsky.social @dfcicancerbio.bsky.social · 18/06/2025
Congratulations Xin!!
010
Reposted by @dfcicancerbio.bsky.social
Alba R Meira @albarmeira.bsky.social · 02/06/2025
Thank you @shalinhnaik.bsky.social for participating in our NIC interview series! We really appreciate it 🤩
011
Reposted by @dfcicancerbio.bsky.social
The Jimmy Fund @thejimmyfund.bsky.social · 03/06/2025
Scooper Bowl® has officially kicked off at Boston City Hall Plaza! Join us now through Thursday, 12-8pm each day, for unlimited ice cream all to benefit @danafarber.bsky.social. 🍦🩷 🎟️: jimmyfund.gives/BSDay #boston #bostonevents #bostonfoodies
A cup of blue ice cream in front of a Friendly's tent at the Jimmy Fund Scooper Bowl.A crowd of people gather at the Jimmy Fund Scooper Bowl.
023
Reposted by @dfcicancerbio.bsky.social
Milka Kostic @milkakostic.bsky.social · 08/05/2025
NEW PREPRINT ALERT: Buhrlage lab in collaboration with @irinabezsonova.bsky.social has developed a new class of USP7 activators! www.biorxiv.org/content/10.1...
biorxiv.org
Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7)
Ubiquitin-specific protease 7 (USP7) is a deubiquitylase essential for cell homeostasis, DNA repair, and regulation of both tumor suppressors and oncogenes. Inactivating USP7 mutations have been assoc...
132
Reposted by @dfcicancerbio.bsky.social
Dana-Farber News @danafarbernews.bsky.social · 08/05/2025
Congrats to @danafarber.bsky.social’s Brian Wolpin, MD, MPH, a 2025 Giants of Cancer Care by @onclive.bsky.social. Dr. Wolpin is recognized for his remarkable achievements in #gastrointestinal and #pancreatic cancer research and clinical practice. ➡️ bit.ly/3RTq7ZS
Brian Wolpin, MD, MPH, of Dana-Farber Cancer Institute
023
Reposted by @dfcicancerbio.bsky.social
Denis Wirtz @deniswirtz.bsky.social · 09/05/2025
188 PhD/graduate fellowships from private foundations, federal agencies and international organizations. Database can be downloaded here: research.jhu.edu/rdt/funding-...
0119
Reposted by @dfcicancerbio.bsky.social
Dana-Farber News @danafarbernews.bsky.social · 16/05/2025
Congratulations to Eric Smith, MD, PhD, @danafarber.bsky.social on receiving the Outstanding New Investigator Award from @asgct.bsky.social. Smith will present on advancing CAR T cell therapy for cancer immunotherapy. #ASGCT2025
Eric Smith, MD, PhD, of Dana-Farber receives Outstanding New Investigator Award
023
Reposted by @dfcicancerbio.bsky.social
Dana-Farber News @danafarbernews.bsky.social · 06/05/2025
Happy #NationalNursesWeek! In this video, @danafarber.bsky.social’s Senior VP for Patient Care Services & CNO Anne Gross is joined by a patient’s mother and other members of the NPCS team in discussing what relationship-based care means to them. bit.ly/44U7WLc
#NationalNursesWeek
032
Reposted by @dfcicancerbio.bsky.social
Nick Polizzi @nickpolizzi.bsky.social · 28/04/2025
Super excited to share a new preprint from our lab on design of small-molecule binding proteins using neural networks! The paper has a bit of everything. A new graph neural network, new design algorithms, and experimental validation. www.biorxiv.org/content/10.1... 🧵🧪
biorxiv.org
Zero-shot design of drug-binding proteins via neural selection-expansion
Computational design of molecular recognition remains challenging despite advances in deep learning. The design of proteins that bind to small molecules has been particularly difficult because it requ...
25523
Reposted by @dfcicancerbio.bsky.social
Boston Protein Design and Modeling Club @bpdmc.org · 03/05/2025
in case you missed the superb seminar that Ben Fry gave back in January, you can now check out the recording youtu.be/IgFgAYQrke4 and the preprint www.biorxiv.org/content/10.1...
youtu.be
Design of small molecule binding proteins using deep learning
YouTube video by Boston Protein Design and Modeling Club
023
Reposted by @dfcicancerbio.bsky.social
Matthew Aquilina @mattaq.bsky.social · 05/05/2025
GelGenie has finally been published in Nature Communications (DOI: doi.org/10.1038/s414...)! GelGenie is a free, open-source app for the one-click extraction of band data from gel images using AI, all bundled within a cross-platform GUI that can be integrated in your workflow immediately. 🧬
251
Reposted by @dfcicancerbio.bsky.social
Dana-Farber News @danafarbernews.bsky.social · 03/04/2025
Recently, the Mass Public Health Council voted unanimously to approve @danafarber.bsky.social’s plans to build a 300-bed cancer hospital in the Longwood Medical Area. Read more about how a stand-alone cancer hospital will increase equitable access to care: bit.ly/4jeqCcu
012
Reposted by @dfcicancerbio.bsky.social
Women in TPD & Induced Proximity @womenintpd.bsky.social · 03/04/2025
From the team of Angela Koehler and colleagues at MIT, an excellent analysis of how CDK9 degradation differs from CDK9 inhibition with respect to Myc regulation. Congratulations! www.cell.com/cell-chemica...
cell.com
Targeted degradation of CDK9 potently disrupts the MYC-regulated network
Toure et al. investigate a known challenge in CDK9 inhibition—the compensatory increase in MYC levels. They demonstrate that a selective CDK9 degrader with rapid kinetics circumvents this effect, prov...
032
Reposted by @dfcicancerbio.bsky.social
Women in TPD & Induced Proximity @womenintpd.bsky.social · 03/04/2025
New preprint out co-led by Hannah Lloyd and Christina Woo at Harvard along with colleagues at the Broad and CeTPD Dundee gives insight on how to detect and discover native substrates of CRBN! www.biorxiv.org/content/10.1...
biorxiv.org
A method for the detection and enrichment of endogenous cereblon substrates
C-Terminal cyclic imides are posttranslational modifications on proteins that are recognized and removed by the E3 ligase substrate adapter cereblon (CRBN). Despite the observation of these modificati...
063
Reposted by @dfcicancerbio.bsky.social
Women in TPD & Induced Proximity @womenintpd.bsky.social · 03/04/2025
Induced proximity modalities at the cell surface! Comprehensive review of emerging approaches and therapeutic possibilities by Carolyn Bertozzi and colleagues at Stanford! www.nature.com/articles/s41...
nature.com
Induced proximity at the cell surface - Nature Biotechnology
Technologies to modulate induced proximity at the cell surface advance the manipulation of diverse biological responses.
053
Reposted by @dfcicancerbio.bsky.social
Dana-Farber News @danafarbernews.bsky.social · 14/04/2025
Congratulations to @danafarbernews.bsky.social’s Matthew Meyerson, MD, PhD, FAACR, @drchoueiri.bsky.social, and Alice T. Shaw, MD, PhD, recipients of @theaacr.bsky.social 2025 Scientific Achievement Awards. bit.ly/4j7m8om
073
Reposted by @dfcicancerbio.bsky.social
Nick Polizzi @nickpolizzi.bsky.social · 31/03/2025
Worth reading and sharing docs.google.com/document/d/1...
docs.google.com
Public Statement on Supporting Science for the Benefit of All Citizens
TO THE AMERICAN PEOPLE We all rely on science. Science gave us the smartphones in our pockets, the navigation systems in our cars, and life-saving medical care. We count on engineers when we drive acr...
001
Reposted by @dfcicancerbio.bsky.social
Dana-Farber News @danafarbernews.bsky.social · 10/03/2025
Congratulations to @danafarber.bsky.social’s Bradley Bernstein, MD, PhD, A. Thomas Look, MD, and William R. Sellers, MD, who have been elected as Fellows of @theaacr.bsky.social Academy Class of 2025. #AACRFellows bit.ly/41RE1Bs
0123
Reposted by @dfcicancerbio.bsky.social
Dana-Farber News @danafarbernews.bsky.social · 29/01/2025
Research in Cell Genomics led by @danafarber.bsky.social's Bradley Bernstein, MD, PhD, presents an AI transformer model developed in collaboration with Google Advanced Sciences which can predict gene expression. bit.ly/42zNVsj
053
Reposted by @dfcicancerbio.bsky.social
Alba R Meira @albarmeira.bsky.social · 13/12/2024
There's no better way to start the new year than by hearing the exciting science of organoids! 🤩 Join us for the first 2025 New Investigator Committee webinar on January 8th.
0196